Dr Reddys secures shareholders nod for amalgamation of Dr Reddys Holdings into company

Published On 2020-01-04 07:20 GMT   |   Update On 2020-01-04 07:20 GMT

The board of Dr Reddy's Laboratories had on July 29, 2019, approved the amalgamation of Dr Reddy's Holdings Ltd, an entity held by the promoter group which holds 24.88 per cent equity shares of Dr Reddy's Laboratories, into the company.


New Delhi: Drug major Dr Reddy's Laboratories on Friday said it has received shareholders nod for proposed amalgamation of Dr Reddy's Holdings Ltd into the company.


The resolution for the scheme was approved by 99.98 per cent votes of the total 13.10 crore votes casted by equity shareholders of the company, it said in a regulatory filing.


21,026 votes, which accounted for the rest 0.02 per cent, were posted against the resolution, it added.


Also Read: Dr Reddys unveils generic version of Nitropress injection in US


The voting was conducted as per the directions of the Hyderabad Bench of the National Company Law Tribunal on November 22, 2019.


The meeting of equity shareholders was convened on January 2, 2020.


The board of Dr Reddy's Laboratories had on July 29, 2019, approved the amalgamation of Dr Reddy's Holdings Ltd, an entity held by the promoter group which holds 24.88 per cent equity shares of Dr Reddy's Laboratories, into the company.


The scheme would lead to simplification of the shareholding structure and reduction of shareholding tiers, the company had said.


"The Promoter Group cumulatively will continue to hold the same number of shares in the Company, pre and post the amalgamation," it had said.


Also Read: Dr Reddys unveils generic Deferasirox Tablets in US
Article Source : PTI

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News